The latest Investing Matters Podcast episode with London Stock Exchange Group's Chris Mayo has just been released. Listen here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRenewi Plc Regulatory News (RWI)

Share Price Information for Renewi Plc (RWI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 660.00
Bid: 658.00
Ask: 660.00
Change: -11.00 (-1.64%)
Spread: 2.00 (0.304%)
Open: 675.00
High: 675.00
Low: 652.00
Prev. Close: 671.00
RWI Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.3 - RENEWI PLC

26 Oct 2023 12:31

RNS Number : 4375R
FIL Limited
26 October 2023
 

FORM 8.3

 

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

 

Rule 8.3 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Full name of discloser:

FMR LLC and/or one or more of its direct or indirect subsidiaries

And

FIL Limited and/or one or more of its direct and indirect subsidiaries

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

RENEWI PLC

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

(e) Date position held/dealing undertaken:

For an opening position disclosure, state the latest practicable date prior to the disclosure

25-October-2023

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

NO

 

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

 

Class of relevant security:

 

GBP1 ordinary

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

1,615,513

 

2.01%

(2) Cash-settled derivatives:

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

 

TOTAL:

 

1,615,513

 

2.01%

 

 

All interests and all short positions should be disclosed

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

(b) Rights to subscribe for new securities (including directors' and other employee options)

 

Class of relevant security in relation to which subscription right exists:

Details, including nature of the rights concerned and relevant percentages:

 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchase/sale

Number of securities

Price per unit

GBP1 ordinary

Sale

16,600

6.68 GBP/Share

GBP1 ordinary

Purchase

112

6.60 GBP/Share

 

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 

(c) Stock-settled derivative transactions (including options)

 

 

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

 

 

 

 

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

 

 

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

None.

 

 

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

None.

 

 

 

(c) Attachments

 

Is a Supplemental Form 8 (Open Positions) attached?

No

 

 

Date of disclosure:

26-October-2023

Contact name:

Ada Coffey

Telephone number:

00 353 1 223 1020

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service. The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RETNKABNDBDDKKB
Date   Source Headline
1st Feb 20177:00 amRNSTotal Voting Rights
31st Jan 20174:13 pmRNSNotice to Noteholders
26th Jan 20178:58 amRNSHolding(s) in Company
25th Jan 20172:01 pmRNSMerger with Van Gansewinkel - approval in Belgium
13th Jan 20178:51 amRNSHolding(s) in Company
4th Jan 20174:39 pmRNSHolding(s) in Company (Correction)
4th Jan 20178:45 amRNSHolding(s) in Company
3rd Jan 20177:00 amRNSTotal Voting Rights
13th Dec 20164:59 pmRNSHolding(s) in Company
5th Dec 20163:27 pmRNSHolding(s) in Company
2nd Dec 20165:20 pmRNSHolding(s) in Company
1st Dec 20167:00 amRNSTotal Voting Rights
23rd Nov 20165:22 pmRNSDirector/PDMR Shareholding
17th Nov 20164:31 pmRNSHolding(s) in Company
17th Nov 20167:30 amRNSAppointment of Joint Broker
17th Nov 20167:00 amRNSHalf-year Report
16th Nov 20164:12 pmRNSHolding(s) in Company
16th Nov 20168:17 amRNSDirectorate Change
14th Nov 20163:21 pmRNSHolding(s) in Company
11th Nov 201610:37 amRNSResults of Rump Placing (Correction)
10th Nov 20163:35 pmRNSHolding(s) in Company
10th Nov 20169:00 amRNSResults of Rump Placing
10th Nov 20167:01 amRNSDirector/PDMR Dealing
10th Nov 20167:00 amRNSResults of Rights Issue and Total Voting Rights
8th Nov 20164:52 pmRNSHolding(s) in Company
1st Nov 201611:36 amRNSTotal Voting Rights
31st Oct 20166:27 pmRNSNotice to Noteholders
26th Oct 20168:16 amRNSAdmission of Nil Paid Rights & Total Voting Rights
24th Oct 201611:53 amRNSResult of Meeting
24th Oct 201610:46 amRNSResult of General Meeting
14th Oct 20167:00 amRNSApproval of van Gansewinkel Groep Shareholders
11th Oct 201610:34 amRNSDirector/PDMR Shareholding
30th Sep 20169:00 amRNSBlock listing Interim Review
29th Sep 20164:52 pmRNSPublication of Combined Circular and Prospectus
29th Sep 20167:41 amRNSProposed Merger with van Gansewinkel Groep
21st Sep 20161:32 pmRNSHolding(s) in Company
20th Sep 20161:38 pmRNSHolding(s) in Company
16th Sep 20167:00 amRNSUpdate on Proposed Merger and Trading Update
12th Sep 20164:02 pmRNSHolding(s) in Company
18th Aug 201611:50 amRNSHolding(s) in Company
2nd Aug 20168:24 amRNSHolding(s) in Company
14th Jul 201612:17 pmRNSResult of AGM
13th Jul 20163:50 pmRNSHolding(s) in Company
7th Jul 20167:34 amRNSProposed Merger with van Gansewinkel Groep
13th Jun 20167:57 amRNSAnnual Report and AGM Notice
24th May 20169:42 amRNSResponse to recent press speculation
24th May 20169:40 amRNSSuspension
19th May 20167:00 amRNSFinal Results
16th May 20163:10 pmRNSHolding(s) in Company
13th May 20166:25 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.